| HOME >> BIOLOGY >> TECHNOLOGY |
845,974 2,668,010
Expenses:
Research and development,
net of tax credits 6,461,991 3,175,663
General and administrative 2,833,070 2,162,020
Interest expense 2,313 547,755
----------------------------------------------------------
9,297,374 5,885,438
----------------------------------------------------------
Loss before the undernoted (8,451,400) (3,217,428)
Interest income 537,128 396,966
Loss on extinguishment of debt - -
------------------------------------------------------------
Loss before income taxes (7,914,272) (2,820,462)
Income taxes:
Current (190,429) -
------------------------------------------------------------
Loss and comprehensive loss
for the period (8,104,701) (2,820,462)
Deficit, beginning of period (21,476,594) (15,032,405)
------------------------------------------------------------
Deficit, end of period (29,581,295) (17,852,867)
------------------------------------------------------------
------------------------------------------------------------
Loss per share - basic and diluted (0.18) (0.09)
------------------------------------------------------------
------------------------------------------------------------
Weighted average common shares
outstanding 44,750,964 32,828,905
------------------------------------------------------------
------------------------------------------------------------
-------------------------------------------------------------------------
'/>"/>
| SOURCE ARIUS Research Inc. Copyright©2007 PR Newswire. All rights reserved |